Tyra Biosciences Inc
(NAS:TYRA)
$
14.09
-0.16 (-1.12%)
Market Cap: 713.00 Mil
Enterprise Value: 359.18 Mil
PE Ratio: 0
PB Ratio: 2.06
GF Score: 40/100 Tyra Biosciences Inc at Bank of America Global Healthcare Conference Transcript
May 11, 2023 / 04:35PM GMT
Release Date Price:
$12.28
(-4.14%)
Hao Shen
BofA Securities, Research Division - Research Analyst
The last day of Bank of America Healthcare Conference here at Vegas. My name is Hao Shen. I'm associated with Jeff Micron, who is the Senior Biopharma Analyst at Bank of America. Today, it's my great honor to have Todd Harris, the CEO of Tyra Biosciences. Todd, welcome.
Todd Harris
Tyra Biosciences, Inc. - Co-Founder, President, CEO, Secretary, Treasurer & Director
Thank you. It's nice to be here.
Questions & Answers
Hao Shen
BofA Securities, Research Division - Research Analyst
Maybe just to kick off the conversation, could you maybe just give a high-level view of Tyra as a company?
Todd Harris
Tyra Biosciences, Inc. - Co-Founder, President, CEO, Secretary, Treasurer & Director
Yes. So Tyra Biosciences is a company focused on precision medicine. We make small molecules. We actually make them from scratch. We do structure-based drug design. And our unique approach is our SNAP chemistry
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot